Lyell Immunopharma, Inc. ( LYEL) - Key Metrics
LYEL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0 | -$8.23 | -$3.56 | -$3.58 |
| 2025Q3 | $0 | -$2.13 | -$1.56 | -$1.57 |
| 2025Q2 | $0 | -$2.89 | -$2.33 | -$2.34 |
| 2025Q1 | $0 | -$3.54 | -$3.71 | -$3.73 |
LYEL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -0.93 |
| 2025Q3 | ? | -1.91 |
| 2025Q2 | ? | -0.77 |
| 2025Q1 | ? | -0.76 |
LYEL
Price: $12.44
52 week price:
Earnings Per Share: -13.62 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 208634
Market Capitalization: 279.3 million